Talimogene laherparepvec (Imlygic)
About This Drug
Talimogene laherparepvec is a live, weakened type 1 herpes simplex virus used to treat cancer. It is given as an injection under the skin (subcutaneously) into your skin cancer.
UPMC Hillman Cancer Center is part of the UPMC family.
Starting Feb. 29, masking is optional but encouraged in UPMC medical facilities and most patient care settings.
Explore this Section
Talimogene laherparepvec is a live, weakened type 1 herpes simplex virus used to treat cancer. It is given as an injection under the skin (subcutaneously) into your skin cancer.